Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Signal‐Transduction Therapy: A Novel Approach to Disease Management
Alexander Levitzki
*
*
Corresponding author for this work
Alexander Silberman Institute of Life Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
172
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Signal‐Transduction Therapy: A Novel Approach to Disease Management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Serositis
100%
Signal Transduction
100%
Disease Management
100%
Diseases
100%
In Vitro
50%
Cancer
50%
Cancer Cell
50%
Atherosclerosis
50%
Protein Tyrosine Kinase
50%
Protein Kinase C
50%
Calcium Signaling
50%
Vascular Smooth Muscle Cell
50%
Rheumatoid Arthritis
50%
Ras Signaling
50%
Psoriasis
50%
Sepsis
50%
Antiestrogen
50%
Inflammatory Arthritis
50%
Keratinocyte
50%
Keyphrases
Beta-blockers
100%
Signal Transduction
100%
Disease Management
100%
Interceptor
75%
Inflammatory Conditions
25%
Tyrosine Kinase
25%
Signaling Pathway
25%
Cancer Cells
25%
Psoriasis
25%
Cell Signaling
25%
Aberrations
25%
Inflammatory Response
25%
Rheumatoid Arthritis
25%
Sepsis
25%
Vascular Smooth muscle Cells
25%
Ca2+ Signaling
25%
Medical Community
25%
Estrogen Antagonist
25%
Inhibit Growth
25%
Protein Kinase C
25%
Proliferative Disease
25%
Psoriatic Keratinocytes
25%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Inflammation
50%
Protein Tyrosine Kinase
25%
Malignant Neoplasm
25%
Psoriasis
25%
Calcium Ion
25%
Protein Kinase C
25%
Atherosclerosis
25%
Rheumatoid Arthritis
25%
Sepsis
25%
Antiestrogen
25%
Inflammatory Arthritis
25%